These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1477459)

  • 1. Lipoprotein(a) levels in the nephrotic syndrome.
    Kanno H; Saito E; Fujioka T; Yasugi T
    Intern Med; 1992 Aug; 31(8):1004-8. PubMed ID: 1477459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T; Kitoh C; Haba T; Hirai J; Wakasugi T; Saga T; Yamazaki Y; Mabuchi H
    Jpn J Med; 1991; 30(1):21-5. PubMed ID: 1830908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
    Faucher C; Doucet C; Baumelou A; Chapman J; Jacobs C; Thillet J
    Am J Kidney Dis; 1993 Dec; 22(6):808-13. PubMed ID: 8250027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD; Azrolan N; Thomas L; Roberts KG; Bostom A; Zhao ZH; Friedman EA
    Am J Kidney Dis; 1995 Jul; 26(1):170-7. PubMed ID: 7611249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum lipoprotein(a) levels in children with corticosensitive nephrotic syndrome.
    Garnotel R; Roussel B; Pennaforte F; Randoux A; Gillery P
    Pediatr Nephrol; 1996 Dec; 10(6):699-701. PubMed ID: 8971882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D; Barbagallo CM; Cascio AL; Cefalù AB; Cavera G; Caldarella R; Marino G; Travali S; Cutaia I; Maringhini S; Notarbartolo A; Averna M
    Kidney Int; 1999 Jun; 55(6):2433-9. PubMed ID: 10354292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipoprotein(a)aemia in nephrotic syndrome.
    Thiery J; Ivandic B; Bahlmann G; Walli AK; Seidel D
    Eur J Clin Invest; 1996 Apr; 26(4):316-21. PubMed ID: 8732490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication.
    Yang X; Wang H; Zhu Z; Deng A
    J Tongji Med Univ; 1998; 18(4):236-8. PubMed ID: 10806854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome.
    Hong SY; Yang DH
    Nephron; 1995; 69(2):125-30. PubMed ID: 7723892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) in nephrotic syndrome.
    Stenvinkel P; Berglund L; Heimbürger O; Pettersson E; Alvestrand A
    Kidney Int; 1993 Nov; 44(5):1116-23. PubMed ID: 8264144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum lipoprotein abnormalities in patients with nephrotic syndrome and effects of steroid therapy].
    Kohtoku N; Okuda F; Shimizu K; Takagi H; Fujii Z; Fujii H; Kusukawa R
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):335-44. PubMed ID: 2747006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
    Nakahara C; Kobayashi K; Hamaguchi H; Kanemoto K; Kashiwagi R; Matsui A
    Pediatr Nephrol; 1999 Oct; 13(8):657-61. PubMed ID: 10502122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT; Heeg JE; Dikkeschei FD; de Zeeuw D; de Jong PE; Dullaart RP
    Nephrol Dial Transplant; 1994; 9(3):244-50. PubMed ID: 8052429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?
    Chan MK; Persaud JW; Ramdial L; Varghese Z; Sweny P; Moorhead JF
    Clin Chim Acta; 1981 Dec; 117(3):317-23. PubMed ID: 7318185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.